Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers.

Menéndez-Menéndez J, Martínez-Campa C.

Int J Endocrinol. 2018 Oct 2;2018:3271948. doi: 10.1155/2018/3271948. eCollection 2018. Review.

2.

Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells.

Alonso-González C, Menéndez-Menéndez J, González-González A, González A, Cos S, Martínez-Campa C.

Int J Oncol. 2018 Feb;52(2):560-570. doi: 10.3892/ijo.2017.4213. Epub 2017 Nov 28.

PMID:
29207126
3.

Complementary actions of melatonin on angiogenic factors, the angiopoietin/Tie2 axis and VEGF, in co‑cultures of human endothelial and breast cancer cells.

González-González A, González A, Alonso-González C, Menéndez-Menéndez J, Martínez-Campa C, Cos S.

Oncol Rep. 2018 Jan;39(1):433-441. doi: 10.3892/or.2017.6070. Epub 2017 Nov 2.

PMID:
29115538
4.

What is known about melatonin, chemotherapy and altered gene expression in breast cancer.

Martínez-Campa C, Menéndez-Menéndez J, Alonso-González C, González A, Álvarez-García V, Cos S.

Oncol Lett. 2017 Apr;13(4):2003-2014. doi: 10.3892/ol.2017.5712. Epub 2017 Feb 10.

5.

Melatonin inhibits angiogenesis in SH-SY5Y human neuroblastoma cells by downregulation of VEGF.

González A, González-González A, Alonso-González C, Menéndez-Menéndez J, Martínez-Campa C, Cos S.

Oncol Rep. 2017 Apr;37(4):2433-2440. doi: 10.3892/or.2017.5446. Epub 2017 Feb 14.

PMID:
28259965
6.

Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis.

Alonso-González C, González A, Martínez-Campa C, Menéndez-Menéndez J, Gómez-Arozamena J, García-Vidal A, Cos S.

Cancer Lett. 2016 Jan 1;370(1):145-52. doi: 10.1016/j.canlet.2015.10.015. Epub 2015 Oct 21.

PMID:
26497762
7.

Melatonin affects the dynamic steady-state equilibrium of estrogen sulfates in human umbilical vein endothelial cells by regulating the balance between estrogen sulfatase and sulfotransferase.

González A, Martínez-Campa C, Alonso-González C, Cos S.

Int J Mol Med. 2015 Dec;36(6):1671-6. doi: 10.3892/ijmm.2015.2360. Epub 2015 Oct 7.

PMID:
26458420
8.

Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double-strand DNA break repair.

Alonso-González C, González A, Martínez-Campa C, Gómez-Arozamena J, Cos S.

J Pineal Res. 2015 Mar;58(2):189-97. doi: 10.1111/jpi.12205. Epub 2015 Jan 26.

PMID:
25623566
9.

Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review).

Cos S, Alvarez-García V, González A, Alonso-González C, Martínez-Campa C.

Oncol Lett. 2014 Aug;8(2):487-492. Epub 2014 May 30.

10.

Antiangiogenic effects of melatonin in endothelial cell cultures.

Alvarez-García V, González A, Alonso-González C, Martínez-Campa C, Cos S.

Microvasc Res. 2013 May;87:25-33. doi: 10.1016/j.mvr.2013.02.008. Epub 2013 Mar 6.

PMID:
23473980
11.

Melatonin modulates aromatase activity and expression in endothelial cells.

Alvarez-García V, González A, Martínez-Campa C, Alonso-González C, Cos S.

Oncol Rep. 2013 May;29(5):2058-64. doi: 10.3892/or.2013.2314. Epub 2013 Feb 28.

PMID:
23450505
12.

Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells.

Alvarez-García V, González A, Alonso-González C, Martínez-Campa C, Cos S.

J Pineal Res. 2013 May;54(4):373-80. doi: 10.1111/jpi.12007. Epub 2012 Sep 27.

PMID:
23013414
13.

Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production.

Alvarez-García V, González A, Alonso-González C, Martínez-Campa C, Cos S.

J Pineal Res. 2012 Apr;52(3):282-90. doi: 10.1111/j.1600-079X.2011.00940.x. Epub 2011 Dec 12.

PMID:
22151118
14.

Melatonin promotes differentiation of 3T3-L1 fibroblasts.

González A, Alvarez-García V, Martínez-Campa C, Alonso-González C, Cos S.

J Pineal Res. 2012 Jan;52(1):12-20. doi: 10.1111/j.1600-079X.2011.00911.x. Epub 2011 Jul 1.

PMID:
21718362
15.

In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin.

González A, Alvarez-García V, Martínez-Campa C, Mediavilla MD, Alonso-González C, Sánchez-Barceló EJ, Cos S.

Curr Cancer Drug Targets. 2010 May;10(3):279-86.

PMID:
20370689
16.

Inhibitory effects of melatonin on sulfatase and 17beta-hydroxysteroid dehydrogenase activity and expression in glioma cells.

González A, Martínez-Campa C, Mediavilla MD, Alonso-González C, Alvarez-García V, Sánchez-Barceló EJ, Cos S.

Oncol Rep. 2010 Apr;23(4):1173-8.

PMID:
20204307
17.

Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells.

Martínez-Campa C, González A, Mediavilla MD, Alonso-González C, Alvarez-García V, Sánchez-Barceló EJ, Cos S.

Br J Cancer. 2009 Nov 3;101(9):1613-9. doi: 10.1038/sj.bjc.6605336. Epub 2009 Sep 22.

18.

Melatonin as a selective estrogen enzyme modulator.

Cos S, González A, Martínez-Campa C, Mediavilla MD, Alonso-González C, Sánchez-Barceló EJ.

Curr Cancer Drug Targets. 2008 Dec;8(8):691-702. Review.

PMID:
19075592
19.

Melatonin modulates the cadmium-induced expression of MT-2 and MT-1 metallothioneins in three lines of human tumor cells (MCF-7, MDA-MB-231 and HeLa).

Alonso-Gonzalez C, Mediavilla D, Martinez-Campa C, Gonzalez A, Cos S, Sanchez-Barcelo EJ.

Toxicol Lett. 2008 Oct 1;181(3):190-5. doi: 10.1016/j.toxlet.2008.07.021. Epub 2008 Aug 6.

PMID:
18755257
20.

Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.

Gonzalez A, Cos S, Martinez-Campa C, Alonso-Gonzalez C, Sanchez-Mateos S, Mediavilla MD, Sanchez-Barcelo EJ.

J Pineal Res. 2008 Aug;45(1):86-92. doi: 10.1111/j.1600-079X.2008.00559.x. Epub 2008 Feb 19.

PMID:
18298468

Supplemental Content

Loading ...
Support Center